Figure 5.
Phospho-PI3K and PI3K expression, Phospho-Akt and Akt expression, Phospho-GSK-3β and GSK-3β expression and Phospho-ERK1/2 and ERK1/2 expression in MIRI rats. (A) Phospho-PI3K and PI3K assay (1–6, represent results of Sham, MIRI, L-TFDM, M-TFDM, H-TFDM, control drug group, respectively, ##P < 0.01; *P < 0.05; **P < 0.01, n = 10). (B) Phospho-Akt and Akt assay (1–6, represent results of Sham, MIRI, L-TFDM, M-TFDM, H-TFDM, control drug group, respectively, ##P < 0.01; *P < 0.05; **P < 0.01, n = 10). (C) Phospho-GSK-3β and GSK-3β assay (1–6, represent results of Sham, MIRI, L-TFDM, M-TFDM, H-TFDM, control drug group, respectively, ##P < 0.01; *P < 0.05; **P < 0.01, n = 10). (D) Phospho-ERK1/2, and ERK1/2 assay (1–6, represent results of Sham, MIRI, L-TFDM, M-TFDM, H-TFDM, control drug group, respectively, ##P < 0.01; *P < 0.05; **P < 0.01, n = 10).